Down-Regulation of eIF4GII by miR-520c-3p Represses Diffuse Large B Cell Lymphoma Development

PLoS Genetics

Volumn 10, Issue 1, 2014, Pages

  Mazan Mamczarz, Krystyna ^a   Zhao, X Frank ^b   Dai, Bojie ^a   Steinhardt, James J ^a   Peroutka, Raymond J ^a   Berk, Kimberly L ^a   Landon, Ari L ^a   Sadowska, Mariola ^a   Zhang, Yongqing ^c   Lehrmann, Elin ^c   Becker, Kevin G ^c   Shaknovich, Rita ^e   Liu, Zhenqiu ^a   Gartenhaus, Ronald B ^a,d  

^a UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d BALTIMORE VA MEDICAL CENTER   (United States)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; INITIATION FACTOR 4G; INITIATION FACTOR 4GIII; MICRORNA; MICRORNA 520C 3P; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; CLONOGENESIS; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LARGE CELL LYMPHOMA; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RNA TRANSLATION; SENESCENCE; TUMOR XENOGRAFT; UPREGULATION;

ANIMALS; CELL AGING; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; EUKARYOTIC INITIATION FACTOR-4G; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MICE; MICRORNAS; RNA, MESSENGER; RNA, SMALL INTERFERING; UP-REGULATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84896702481     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1004105     Document Type: Article

References (62)

1. Lazaris-Karatzas A, Montine KS, Sonenberg N, (1990) Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap. Nature 345: 544-547.
2. Clemens MJ, (2004) Targets and mechanisms for the regulation of translation in malignant transformation. Oncogene 23: 3180-3188.
3. Polunovsky VA, Bitterman PB, (2006) The cap-dependent translation apparatus integrates and amplifies cancer pathways. RNA Biol 3: 10-17.
4. Graff JR, Konicek BW, Vincent TM, Lynch RL, Monteith D, et al. (2007) Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity. J Clin Invest 117: 2638-2648.
5. Shay JW, Roninson IB, (2004) Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 23: 2919-2933.
6. Gingras AC, Raught B, Sonenberg N, (1999) eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem 68: 913-963.
7. Caron S, Charon M, Cramer E, Sonenberg N, Dusanter-Fourt I, (2004) Selective modification of eukaryotic initiation factor 4F (eIF4F) at the onset of cell differentiation: recruitment of eIF4GII and long-lasting phosphorylation of eIF4E. Mol Cell Biol 24: 4920-4928.
8. Wang S, Rosenwald IB, Hutzler MJ, Pihan GA, Savas L, et al. (1999) Expression of the eukaryotic translation initiation factors 4E and 2alpha in non-Hodgkin's lymphomas. Am J Pathol 155: 247-255.
9. Meric F, Hunt KK, (2002) Translation initiation in cancer: a novel target for therapy. Mol Cancer Ther 1: 971-979.
10. Ruggero D, Montanaro L, Ma L, Xu W, Londei P, et al. (2004) The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. Nat Med 10: 484-486.
11. Wendel HG, De Stanchina E, Fridman JS, Malina A, Ray S, et al. (2004) Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature 428: 332-337.
12. Moerke NJ, Aktas H, Chen H, Cantel S, Reibarkh MY, et al. (2007) Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G. Cell 128: 257-267.
13. Bordeleau ME, Robert F, Gerard B, Lindqvist L, Chen SM, et al. (2008) Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model. J Clin Invest 118: 2651-2660.
14. Gradi A, Imataka H, Svitkin YV, Rom E, Raught B, et al. (1998) A novel functional human eukaryotic translation initiation factor 4G. Mol Cell Biol 18: 334-342.
15. Imataka H, Gradi A, Sonenberg N, (1998) A newly identified N-terminal amino acid sequence of human eIF4G binds poly(A)-binding protein and functions in poly(A)-dependent translation. The EMBO Journal 17: 7480-7489.
16. Fukuchi-Shimogori T, Ishii I, Kashiwagi K, Mashiba H, Ekimoto H, et al. (1997) Malignant transformation by overproduction of translation initiation factor eIF4G. Cancer Res 57: 5041-5044.
17. Bauer C, Diesinger I, Brass N, Steinhart H, Iro H, et al. (2001) Translation initiation factor eIF-4G is immunogenic, overexpressed, and amplified in patients with squamous cell lung carcinoma. Cancer 92: 822-829.
18. Avdulov S, Li S, Michalek V, Burrichter D, Peterson M, et al. (2004) Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells. Cancer Cell 5: 553-563.
19. Tu L, Liu Z, He X, He Y, Yang H, et al. (2010) Over-expression of eukaryotic translation initiation factor 4 gamma 1 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma. Mol Cancer 9: 78.
20. Ambros V, (2001) microRNAs: tiny regulators with great potential. Cell 107: 823-826.
21. Meltzer PS, (2005) Cancer genomics: small RNAs with big impacts. Nature 435: 745-746.
22. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103: 2257-2261.
23. Nana-Sinkam SP, Croce CM, (2010) MicroRNA in chronic lymphocytic leukemia: transitioning from laboratory-based investigation to clinical application. Cancer Genet Cytogenet 203: 127-133.
24. Benhamed M, Herbig U, Ye T, Dejean A, Bischof O, (2012) Senescence is an endogenous trigger for microRNA-directed transcriptional gene silencing in human cells. Nature Cell Biol 14: 266-275.
25. Basso K, Sumazin P, Morozov P, Schneider C, Maute RL, et al. (2009) Identification of the human mature B cell miRNome. Immunity 30: 744-752.
26. Malumbres R, Sarosiek KA, Cubedo E, Ruiz JW, Jiang X, et al. (2009) Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. Blood 113: 3754-3764.
27. Rai D, Karanti S, Jung I, Dahia PL, Aguiar RC, (2008) Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma. Cancer Genet Cytogenet 181: 8-15.
28. Mu P, Han YC, Betel D, Yao E, Squatrito M, et al. (2009) Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev 23: 2806-2811.
29. Craig VJ, Cogliatti SB, Imig J, Renner C, Neuenschwander S, et al. (2011) Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1. Blood 117: 6227-6236.
30. Craig VJ, Tzankov A, Flori M, Schmid CA, Bader AG, (2012) Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo. Leukemia 26: 2421-2424.
31. Babar IA, Cheng CJ, Booth CJ, Liang X, Weidhaas JB, et al. (2012) Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma. Proc Natl Acad Sci U S A 109: E1695-704.
32. Di Lisio L, Sánchez-Beato M, Gómez-López G, Rodríguez ME, Montes-Moreno S, et al. (2012) MicroRNA signatures in B-cell lymphomas. Blood Cancer J 2: e57.
33. Stumpf CR, Ruggero D, (2011) The cancerous translation apparatus. Curr Opin Genet Dev 21: 474-483.
34. Hagner PR, Schneider A, Gartenhaus RB, (2010) Targeting the translational machinery as a novel treatment strategy for hematologic malignancies. Blood 115: 2127-2135.
35. Horvilleur E, Wilson LA, Willis AE, (2010) Translation deregulation in B-cell lymphomas. Biochem Soc Trans 38: 1593-1597.
36. Wang W, Yang X, Cristofalo VJ, Holbrook NJ, Gorospe M, (2001) Loss of HuR is linked to reduced expression of proliferative genes during replicative senescence. Mol Cell Biol 21: 5889-5898.
37. Fabian MR, Sonenberg N, Filipowicz W, (2010) Regulation of mRNA translation and stability by microRNAs. Annual Review of Biochemistry 79: 351-379.
38. Ho BC, Yu SL, Chen JJ, Chang SY, Yan BS, et al. (2011) Enterovirus-induced miR-141 contributes to shutoff of host protein translation by targeting the translation initiation factor eIF4E. Cell Host Microbe 9: 58-69.
39. Bellodi CN, Kopmar N, Ruggero D, (2010) Deregulation of oncogene-induced senescence and p53 translational control in X-linked dyskeratosis congenita. EMBO J 29: 1865-1876.
40. Serrano M, (2012) Dissecting the role of mTOR complexes in cellular senescence. Cell Cycle 11: 2231-2232.
41. Ramírez-Valle F, Braunstein S, Zavadil J, Formenti SC, Schneider RJ, (2008) eIF4GI links nutrient sensing by mTOR to cell proliferation and inhibition of autophagy. J Cell Biol 181: 293-307.
42. Young AR, Narita M, (2010) Connecting autophagy to senescence in pathophysiology. Curr Opin Cell Biol 22: 234-240.
43. Huang Q, Gumireddy K, Schrier M, le Sage C, Nagel R, et al. (2008) The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 10: 202-210.
44. Liu P, Wilson MJ, (2012) miR-520c and miR-373 upregulate MMP9 expression by targeting mTOR and SIRT1, and activate the Ras/Raf/MEK/Erk signaling pathway and NF-κB factor in human fibrosarcoma cells. J Cell Physiol 227: 867-876.
45. Keklikoglou I, Koerner C, Schmidt C, Zhang JD, Heckmann D, et al. (2012) MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways. Oncogene 31: 4150-4163.
46. Shay JW, Roninson IB, (2004) Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 23: 2919-2933.
47. Ewald JA, Desotelle JA, Wilding G, Jarrard DF, (2010) Therapy-induced senescence in cancer. J Natl Cancer Inst 102: 1536-1546.
48. Lleonart ME, Carnero A, Paciucci R, Wang ZQ, Shomron N, (2011) Cancer, senescence, and aging: translation from basic research to clinics. J Aging Res pp. 692301 doi: 10.4061/2011/692301.
49. Nardella C, Clohessy JG, Alimonti A, Pandolfi PP, (2011) Pro-senescence therapy for cancer treatment. Nat Rev Cancer 11: 503-551.
50. Calin GA, Croce CM, (2006) MicroRNA signatures in human cancers. Nature Reviews Cancer 6: 857-866.
51. Lawrie CH, Chi J, Taylor S, Tramonti D, Ballabio E, et al. (2009) Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma. J Cell Mol Med 13: 1248-1260.
52. Mazan-Mamczarz K, Gartenhaus RB, (2013) Role of microRNA deregulation in the pathogenesis of diffuse large B-cell lymphoma (DLBCL). Leuk Res 37: 1420-1428.
53. Chi J, Ballabio E, Chen XH, Kušec R, Taylor S, et al. (2011) MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival. Biol Direct 6: 23.
54. Ibrahim HA, Amen F, Reid AG, Naresh KN, (2011) BCL3 rearrangement, amplification and expression in diffuse large B-cell lymphoma. Eur J Haematol 87: 480-485.
55. Michaux L, Dierlamm J, Wlodarska I, Bours V, Van den Berghe H, (1997) t(14;19)/BCL3 rearrangements in lymphoproliferative disorders: a review of 23 cases. Cancer Genet Cytogenet 94: 36-43.
56. De Benedetti A, Graff JR, (2004) eIF-4E expression and its role in malignancies and metastases. Oncogene 23: 3189-3199.
57. Wendel HG, Silva RL, Malina A, Mills JR, Zhu H, et al. (2007) Dissecting eIF4E action in tumorigenesis. Genes Dev 21: 3232-3237.
58. Greeve J, Philipsen A, Krause K, Klapper W, Heidorn K, et al. (2003) Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas. Blood 101: 3574-8350.
59. Mazan-Mamczarz K, Hagner PR, Zhang Y, Dai B, Lehrmann E, et al. (2011) ATM regulates a DNA damage response posttranscriptional RNA operon in lymphocytes. Blood 117: 2441-2450.
60. Mazan-Mamczarz K, Hagner PR, Dai B, Wood WH, Zhang Y, et al. (2008) Identification of transformation-related pathways in a breast epithelial cell model using a ribonomics approach. Cancer Res 68: 7730-7735.
61. Dai B, Zhao XF, Mazan-Mamczarz K, Hagner P, Corl S, et al. (2011) Functional and molecular interactions between ERK and CHK2 in diffuse large B-cell lymphoma. Nat Commun 2: 402.
62. Dai B, Zhao XF, Hagner P, Shapiro P, Mazan-Mamczarz K, et al. (2009) Extracellular signal-regulated kinase positively regulates the oncogenic activity of MCT-1 in diffuse large B-cell lymphoma. Cancer Res 69: 7835-7843.